SUDA Pharmaceuticals (ASX:SUD), a leader in oro-mucosal drug delivery, is pleased to advise that it has received a refund of $927,970 from the Australian Taxation Office under the R&D Tax Incentive for the 2019 financial year.
For more information, download the attached PDF.
Download this document
